News

Find News

Filter articles

Applied Filters

Showing 691 to 700 of 706 results

IPAB rejects Monsanto plant patent

India15-07-2013

India’s Intellectual Property Appellate Board has affirmed that US agricultural company Monsanto cannot obtain a patent covering transgenic plants, two years after it was first rejected.

Novartis strikes vaccine licensing deal with Indian biopharma

India08-07-2013

Novartis has signed a development and licensing agreement with Indian biopharmaceutical company Biological E Limited (BioE) to deliver two vaccines that protect against typhoid and paratyphoid fevers.

US Supreme Court strikes Myriad blow

US13-06-2013

The US Supreme Court has ruled that isolated human DNA is not patent eligible and has struck down patents owned by biotech company Myriad, ending a long-running and controversial case.

Patents covering IVF test spark row

US29-05-2013

Members of the scientific community have blasted Stanford University and US biotechnology company Auxogyn for their involvement in patenting a test designed to increase the success of in vitro fertilisation (IVF).

Hi-tech and life sciences dominate at EPO awards

EU29-05-2013

The inventor of the world’s first flat-panel liquid crystal display, Martin Schadt, was among a number of winners at the European Patent Office European Inventor Award 2013.

WHO issues IP warning over MERS virus

28-05-2013

The World Health Organization has warned that “no IP will stand in the way of public health actions” amid the spreading of a deadly global virus.

RuiYi joins with Genor to develop cancer treatment

China, US20-05-2013

San Diego-Shanghai biotechnology startup RuiYi Inc has entered into an exclusive license and collaborative development agreement with Shanghai-based Genor BioPharma to develop the RYI-008 molecule in China.

Ideas Matter: the importance of IP in the fight against cancer

UK20-05-2013

On May 14, healthcare experts met in London to share and discuss developments in cancer detection, prevention, treatment and maintenance, and how IP protection and management are vital in attracting investment.

Ideas Matter: Philips and Microsoft in life sciences

UK20-05-2013

At the Ideas Matter roundtable last week LSIPR spoke to Maaike van Velzen, general manager of Philips Group Innovation’s IP and Standards division, about the importance of using IP to promote the company’s vision.

IP key to US biosimilars success – report

US15-05-2013

Strong IP knowledge is one of four key factors to succeeding in the burgeoning US biosimilars market, according to an industry report.

Showing 691 to 700 of 706 results

LSIPR